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Abstract—Phased array transducers are increasingly prevalent
in a therapeutic contex as they facilitate precise control of the
beam intensity and focus. To produce enough acoustic energy for
ablation, large and costly amplifiers are required. Miniaturised
switched circuits provide an alternative that is both more cost
effective and more efficient. However, the high Q factor and
curved geometry of a therapeutic transducer lends itself to
grating lobes that deposit energy in undesirable areas when
driven with switched circuitry. In this work, harmonic reduction
pulse with modulation (HRPWM) is applied to a simulation of
a therapeutic array. An array was simulated along with a skull
that varied in attenuation. A number of switching schemes were
tested and where possible, their amplitude was adjusted to reduce
pressure variation in the acoustic field after propagation through
the skull. Of the switched schemes tested, HRPWM performed
best; reducing harmonically induced grating lobes by 12 dB and
limiting pressure field variance to 0.1 dB which increases intensity
at the focal point and makes therapy more efficient.
Index Terms—frequency modulation, ultrasonic transducers,
harmonic distortion, ultrasonic therapy
I. INTRODUCTION
Phased array transducers have long been utilised in medical
imaging partly because ultrasonic energy can be dynamically
focused on a small regions of interest, which can improve
contrast and resolution. More recently, higher power phased
arrays have been applied to ultrasonic therapy as they can
facilitate dynamic beamforming and more accurate ablation
[1]–[3]. In transcranial therapy [4] they are of particular
necessity to compensate skull’s varying attenuation [5]–[7].
To achieve the electrical powers required for tissue ablation,
therapeutic excitation circuits typically use class A amplifiers
which are costly and inefficient [8]. As the element count of
therapeutic systems increases, so does the physical size and
cost. If phased array ultrasonic therapy is to be more widely
adopted, the cost of these systems should be minimised as
should their physical size to increase portability.
An obvious candidate to reduce the size and cost of the
excitation circuits might be to use switched excitation [9],
[10]. These circuits however produce powerful third and fifth
harmonics, which are within the bandwidth of the transducer.
With phased array beamforming, the amplitude of grating
lobes depends on the ratio of element spacing to wavelength.
These harmonics effectively have a smaller wavelength and so
less of their energy will be directed at the focal point. This
deposits harmful ultrasonic energy away from the intended
target. The concave shape of therapeutic transducers makes
this particularly hazardous because the grating lobes exist
within the field of view. A solution that is employed is to
use passive power filters, but these are also large.
By using three discrete voltage levels and governing the
switching angle, authors have demonstrated techniques to
reduce the third harmonic induced by switching [11]. The
drawback to using third harmonic reduction however is that
amplitude control is not possible. More recently, HRPWM
(Harmonic Reduction Pulse Width Modulation) has been
demonstrated to reduce both the third and fifth harmonics
whilst retaining amplitude control [12]–[14]. HRPWM has
supported a number of biomedical and NDT imaging pub-
lications [15], [16].
Switched excitation will facilitate reductions in cost and
improve efficiency of HIFU array systems. In this paper
several excitation schemes were investigated to determine
which were best able to minimise switching induced grating
lobes and retain amplitude control.
II. METHOD
A prostate HIFU array [17] was simulated in Field II [18].
The concave array consists of 64 elements, 50 mm in height
and 1.5 mm in width. The array elements are distributed on
an arc with a radius of 100 mm. The natural focus of the
transducer is at 0 mm laterally and -100 mm axially. The
excitation for the array is a 1 MHz continuous wave, and
delays were applied to focus the beam at -40 mm laterally
and 50 mm axially. To reduce simulation time, only part of the
field of view was simulated. Figure 1 depicts the transducer,
its focal points and the simulation area.
The impulse response of a 10 element IMASONIC HIFU
transducer [19] was obtained using a needle hydrophone. The
hydrophone was placed at the transducer natural focal point
and the peak excitation voltage was kept under 20 V to reduce
the effects of any non-linear propagation. The peak pressure
was 1.5 MPa. This impulse response was input into field II to
improve modelling accuracy.
Four different excitation schemes are considered; analog,
bipolar, third harmonic reduction (3HR) and HRPWM. Analog
is defined as
a(t) = sin(2pift) (1)
where f is 1 MHz. The bipolar excitation is formed by finding
the sign of the analog excitation:
b(t) = sgn{sin(2pift)} (2)
Third harmonic reduction is defined as
c(t) =


1, for sin(7pi/6) < a(t) ≥ sin(pi/6)
0, for sin(7pi/6) ≤ a(t) ≥ sin(pi/6)
−1, for sin(7pi/6) ≥ a(t) < sin(pi/6)

 (3)
HRPWM comprises multiple DSP stages and is difficult to
represent analytically. Fundamentally, it involves modulating
PWM switching angles in a manner that modulates the de-
sired amplitude of the fundamental component of the signal
without effecting the amplitude of undesired harmonics. The
waveforms may be truly arbitrary in frequency and amplitude.
Under the area of each element exists a piece of skull
that varies randomly between 12 and 14 dB in attenuation.
Here, attempts are made to adjust the power to minimise the
effects of the attenuation and maximise energy at the focal
point as is the case with transcranial therapy. When focusing
ultrasound through the rib cage however, the opposite may
be desirable; acoustic power is adjusted to reduce heating in
the highly absorbing ribs. Either way, it will be demonstrated
that amplitude control is an essential requirement for an HIFU
system.
For analog excitation, the amplitude is adjusted for each
element exactly. In a switched excitation phased array system
however, the rail voltage can only be adjusted for the whole
array and not for each element. Since both the bipolar and 3HR
schemes have no inherent amplitude modulation capability,
the rail voltage is set to the mean of the analog amplitude
coefficients. For HRPWM, which can modulate amplitude,
the rail voltage is set to the maximum amplitude coefficient.
Figure 2 shows an example of each waveform. For the bipolar
and 3HR waveforms, the rail voltage is the same as the
average analog amplitude coefficient. For HRPWM however,
the rail voltage exceeds the peak of the analog waveform as
to accommodate the higher amplitude coefficient of another
element. To retain the equivalent amplitude, the pulse width
has been adjusted automatically. The voltage has arbitrary
units because the density of the medium is not taken into
consideration.
III. RESULTS AND DISCUSSION
Figure 3 shows the beam profiles for all the excitations.
To create a beam profile, the maximum amplitude is obtained
at each point then the absolute signal maximum is used as a
reference to convert the image into power. Each excitation and
image uses its own unique reference. The resulting images are
Fig. 1: An axonometric view of transducer geometry. The
transducer has 64 elements and has a geometric focus at 100
mm which is indicated by the red dot. During simulations
delays are applied to each element to steer the beam to
the focal point which the blue dot represents. To reduce
simulation time, only the area bounded by the green rectangle
is simulated.
Fig. 2: A single cycle of the continuous wave from one
element using the four different excitations. The 3HR and
bipolar voltage rails are set to the mean of the amplitude
coefficients. The HRPWM rail is set higher to accommodate
higher amplitude coefficients.
thresholded at -20 dB. All excitation schemes correctly focus
the beam to a small point. For the analogue excitation, there is
little energy outside of the focal spot. For bipolar excitation,
harmonics form a grating lobe of approximately -12 dB in
addition to other large deposits of energy away from the focal
point. Both 3HR excitations and HRPWM reduce the density
of this energy, with HRPWM performing best.
Figure 4 shows acoustic pressure after the sound has propa-
gated through the skull. Only three of the four excitations are
shown because bipolar and 3HR have no amplitude modulation
capabilities, and so produce similar results. Since arbitrary
units have been used in simulation, the results in this figure
are presented as in decibels, with the RMS pressure of the
maximum analog excitation being used as a reference. When
analog excitation is used the pressure field exhibits an even
attenuation of approximately 14 dB, irrespective of attenua-
tion. This is the expected behaviour because the amplitude
of the analog excitations for each element can be precisely
controlled. For the bipolar and 3HR excitations, the rail voltage
was set to the mean to reduce the variance in acoustic pressure
as much as possible. Despite this, the pressure varies between
12 and 14 dB compared with the reference. When HRPWM
excitation is used the variation is approximately 0.1 dB and
nominally 13.5 dB.
The results show that overall analog excitation performs
best in both amplitude control and harmonic control which
was expected. The bipolar excitation is the worst performing
as it is unable to perform any amplitude control and because of
its high harmonic distortion, grating lobes and other deposits
of energy exist outside the focal spot. Both 3HR and HRPWM
schemes were able to reduce, but not completely remove the
grating lobe, with HRPWM performing best. Whilst 3HR
excitation was able to reduce the grating lobe, it was unable to
compensate for variations in skull absorption leading to a large
variance in acoustic pressure and so subsequently increased
the size of the focal region. HRPWM was able to reduce
the switching-induced grating lobes whilst retaining amplitude
control.
IV. CONCLUSION
The desire to dynamically change the focal point is one
factor that has led to the adoption of phased array trans-
ducers in therapeutic ultrasound. Another motivator unique to
transcranial therapy is compensation of localised attenuation
in the skull. Either way, the number of driving elements in
therapeutic array systems continue to increase. These systems
use large, costly and inefficient class A amplifiers to generate
the desired acoustic power. This culminates in systems that
are costly and unwieldy in size.
Switched excitation could be used to resolve the cost and
size implications of class A amplifiers. In this paper, a typical
HIFU array was simulated with a variety of different excitation
techniques. A skull with an attenuation that varies under each
element was also simulated. Where possible, the attenuation
was compensated for to reduce pressure variance. The beam
(a) Analog Excitations
(b) Bipolar Excitation
(c) 3HR Excitation
(d) HRPWM Excitation
Fig. 3: Beam profiles for all four excitations. The beam is
focused at 40, -50 mm. The bipolar excitation exhibits grating
lobes which both 3HR and HRPWM schemes can remove.
(a) Analog Excitation
(b) Bipolar Excitation
(c) HRPWM Excitation
Fig. 4: Pressure field following subtraction of hard tissue
attenuation for analog, bipolar and HRPWM excitations. The
maximum pre-attenuation pressure from analog excitation is
used as a reference. Even colour distribution shows good am-
plitude control and inconsistent colour shows poor amplitude
control.
was focused to a point and the results pressure fields were mea-
sured. It was found that the bipolar excitation’s high harmonic
content amassed as fields of energy away from the focal spot.
It was also found that the the variance in the pressure after
propagation through the skull was great. 3HR excitation was
able to reduce the harmonic induced grating lobes, however
pressure variance remained unsatisfactory. HRPWM excitation
further reduced the grating lobes and was able to to reduce
pressure variance to a satisfactory level.
It was found that some form of sophisticated switching
scheme is required to miniaturise HIFU circuitry. HRPWM
is a viable alternative to costly, inefficient and expansive
class A amplifiers normally used in phased array therapeutic
ultrasound. Further work should be conducted to observe
the beam profile experimentally, particularly with transcranial
therapy where the arrays are large and the geometry lends
itself to the production of harmful grating lobes.
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